Pharma and Biotech Daily: Elevidys setback, Lilly's big commitment, and more!

Pharma and Biotech Daily: Elevidys setback, Lilly's big commitment, and more!

Author: Pharma and BioTech News July 28, 2025 Duration: 1:13
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. The European Medicines Agency's CHMP did not recommend approving Elevidys for ambulatory patients with Duchenne muscular dystrophy, dealing a blow to Sarepta. FDA is rumored to request new data for Elevidys, leading to uncertainty as FDA considers a new study for the drug. In other news, Eli Lilly commits $856 million to Gate Bioscience for a new class of medicines, while Rocket trims headcount and pipeline focus. Roche also drops an early obesity asset as layoffs continue in the biopharma industry, with companies like Adicet optimizing their pipelines. Novartis makes a billion-dollar drug discovery deal with Matchpoint, and the FDA opens a pilot run of the commissioner voucher program.Stay tuned for more updates on the latest developments in the pharmaceutical and biotech world.

Support the show


Every morning, the world of life sciences shifts with new clinical data, strategic deals, and regulatory decisions. Keeping pace with it all is a full-time job. Pharma and BioTech Daily is designed to be that essential, efficient briefing for professionals and investors who need the signal through the noise. This daily podcast delivers a concise, human-curated audio update that synthesizes the most critical developments from the previous day. You’ll hear clear summaries of pipeline milestones, merger and acquisition activity, policy changes, and corporate strategy shifts-all contextualized for their real-world impact. The production leverages AI tools to monitor vast data streams, but each episode is carefully supervised and narrated by editors to ensure accuracy and relevance. It’s for anyone who builds companies in this space, manages portfolios, or makes strategic decisions where science meets business. Tune in for a focused, factual, and time-saving digest that fits into your morning routine, brought to you by the team at Pharma and BioTech News and produced by the boutique studio OWITH.ai. This isn't about lengthy interviews or opinion; it's a streamlined tool to inform your day in the complex, fast-moving pharma and biotech landscape.
Author: Language: English Episodes: 236

Pharma and BioTech Daily
Podcast Episodes
Breakthroughs in Myeloma Treatment and Strategic Shifts [not-audio_url] [/not-audio_url]

Duration: 6:23
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the latest innovations, strategic shifts, and regulatory updates s…
Pharma's Future: Innovation, Regulation, and Global Trends [not-audio_url] [/not-audio_url]

Duration: 6:22
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a landscape marked by rapid transformations and strategic maneuver…
Navigating Innovation: Key Trends in Pharma 2026 [not-audio_url] [/not-audio_url]

Duration: 9:21
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. This morning, we're diving into a series of fascinating updates that underline the vibr…
Biotech Breakthroughs: M&A Surge and AI Innovation [not-audio_url] [/not-audio_url]

Duration: 6:24
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of significant events and trends reshaping the indust…
Immuno-Oncology Advances and CRISPR Innovations: Key Industry Shifts [not-audio_url] [/not-audio_url]

Duration: 5:21
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of transformative updates reshaping drug development and…
Eli Lilly's Strategic Move: Transforming Inflammation Therapeutics [not-audio_url] [/not-audio_url]

Duration: 9:28
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.The industry continues to navigate a dynamic landscape marked by significant scientific…
Breakthroughs and Legal Battles: Pharma's 2026 Horizon [not-audio_url] [/not-audio_url]

Duration: 5:36
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of groundbreaking advancements and strategic movements sh…
2026 Pharma Breakthroughs: Lupus, Obesity, and Regulatory Shifts [not-audio_url] [/not-audio_url]

Duration: 4:41
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today we're diving into a landscape rich with scientific advancements, strategic indust…
2025 Biotech Breakthroughs: From AI to Oncology Advances [not-audio_url] [/not-audio_url]

Duration: 6:34
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. As we delve into the year 2025, it's clear that the pharmaceutical and biotech industri…
Strategic Shifts and Breakthroughs in Pharma 2025 [not-audio_url] [/not-audio_url]

Duration: 7:05
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of significant events that are shaping the landscape of t…